Vol 5 _1_ - Cont. J. Pharm Sci. - Wilolud Journals

More documents

Recommendations

Info

O.R. Omobuwajo et al.,: Continental J. Pharmaceutical Sciences 5: 1 - 10, 2011Table 1 Results of antimicrobial Assay of Crude Extracts and Herbal soap at 3,5,and 8% Herbal ContentConcentration(g/L)025 0.50 1.00 10.00 20.00 40.00A Crude LeafExtractPs + + + + + -Ec + + + + + -Sa + + + - - -Sc + + + - - -Bs + + + + + +Bc + - - - - -B (8%) Ps + + + + + +Ec + + + + + -Sa + + - - - -Sc + + - - - -Bs + + + + + -Bc - - - - - -C (5%) Ps + + + + + -Ec + + + + + -Sa - - - - - -Sc + - - - - -Bs + + + + + -Bc - - - - - -D(3%) Ps + + + + + -Ec + + + + + -Sa + - - - - -Sc + + - - - -Bs + + + + - -Bc - - - - - -Key:Ps: Pseudomonas aeruginosa (ATCC 19429), Ec: Escherichia coli (NCTC 10416), Sa: Staphylococcus aureus (NCTC 6571), Sc: Staphylococcus aureus(Clinical isolates), Bs: Bacillus subtilis (NCTC 8326), Bc: Bacillus cereus (Clinical isolates).+: Growth observed, -: Inhibition8
O.R. Omobuwajo et al.,: Continental J. Pharmaceutical Sciences 5: 1 - 10, 2011Table 2 Results of Antimicrobial Assay of Herbal soap against clinical isolates at 8% Herbal content8%Concg/LB(NCTC8326E(NCTC10416 PsS(NCTC6571 S(HR1S(ATC Cp(NCYC))(ATCC19429) )) S(04TW) S2 S3 C) 6)50 + + + - - - - - - -40 + + + - - - - - - -30 + + + - - - - - - -20 + + + - - - - - - -10 + + + - - - + - - -5 + + + - - - + + - -1 + + + - - - + + - +0.5 + + + + + - + + - +0.25 + + + + + - + + + +KEY: CLINICAL ISOLATES, B: B. subtilis, E: E. Coli, Ps: Pseudomonas aeruginosa, S(NCTC): Staphylococcus aureus, S(ATCC):Staphylococcus aureus, Cp: Candida pseudotropicalis. +: no inhibition (Growth observed), -: inhibited (MIC).Table 3 Results of Antimicrobial Assay of Herbal soap against clinical isolates at 5% Herbal content5%Concg/LB(NCTC8326E(NCTC10416 PsS(NCTC6571 S(HR1S(ATC Cp(NCYC))(ATCC19429) )) S(04TW) S2 S3 C) 6)50 - + + - - - - - - -40 - + + - - - - - - -30 - + + - - - - - - -20 - + + - - - - - - -10 - + + - - - + - - -5 + + + - - - + + - -1 + + + + + + + + - +0.5 + + + + + + + + + +0.25 + + + + + + + + + +KEY: CLINICAL ISOLATES, B: B. Subtilis, E: E. Coli, Ps: Pseudomonas aeruginosa, S(NCTC): Staphylococcus aureus, S(ATCC): Staphylococcus aureus,Cp: Candida pseudotropicalis. +: no inhibition (Growth observed), -: inhibited (MIC).9
Page 1 and 2: Continental J. Pharmaceutical Scien
Page 3 and 4: O.R. Omobuwajo et al.,: Continental
Page 5 and 6: O.R. Omobuwajo et al.,: Continental
Page 7: O.R. Omobuwajo et al.,: Continental

Vol 5 _1_ - Cont. J. Pharm Sci. - Wilolud Journals

Create successful ePaper yourself

Delete template?

Save as template?